I agree, the share price fall appears like an over reaction. Don’t for get the full impact of Thomas Cook will not be impacting us until June next year as we are still in a earnings transition phase (if it am interpreting the annual report correctly
page 16 of annual report
The transition phase (during which we recognise no revenue from sales made to Thomas Cook) is due to end in May 2019 and from 1 June 2019, we will switch to a volume based earning arrangement which ioffers significant revenue and EBITDA potential.
IMHO
regard Inda
Web Chart, page-298
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WEB (ASX) to my watchlist
|
|||||
Last
$8.06 |
Change
0.000(0.00%) |
Mkt cap ! $3.152B |
Open | High | Low | Value | Volume |
$8.08 | $8.09 | $7.93 | $13.81M | 1.722M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3832 | $8.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.08 | 11602 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3832 | 8.060 |
4 | 6677 | 8.040 |
2 | 5891 | 8.030 |
2 | 12852 | 8.020 |
2 | 7570 | 8.010 |
Price($) | Vol. | No. |
---|---|---|
8.080 | 11602 | 2 |
8.090 | 4117 | 2 |
8.100 | 4154 | 3 |
8.110 | 6677 | 3 |
8.120 | 12852 | 2 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
WEB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online